GlassScriptPhysician profile
Dimitrios Stefanidis
NPI 1386663466
$68,246.36
in general payments reported to CMS, 2019-2025
19 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,599 · 2020: $24.13 · 2021: $121 · 2022: $4,432 · 2023: $16K · 2024: $28K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Travel and Lodging: $8,507 · Food and Beverage: $3,500 · Education: $39.95 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,009.27 |
| Travel and Lodging | $8,506.82 |
| Food and Beverage | $3,499.56 |
| Education | $39.95 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $50,373.10 | 2023-2025 | Harmonic, Echelon; Endopath |
| Applied Medical Resources Corporation | $7,700.21 | 2022-2025 | Epix Universal Clip Applier |
| Intuitive Surgical, INC. | $3,940.41 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,875.66 | 2025 | |
| Medtronic, INC. | $1,637.87 | 2022-2024 | Signia, Ligasure, Parietene Ds |
| Covidien LP | $650.00 | 2019 | |
| Ethicon US, LLC | $246.37 | 2023-2025 | Harmonic, Echelon; Endopath, Vistaseal |
| Echosens North America, INC. | $149.38 | 2025 | Fibroscan |
| Tela Bio, INC. | $145.33 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Reshape Lifesciences INC. | $121.38 | 2023 | |
| Conmed Corporation | $108.70 | 2023 | Airseal |
| W. L. Gore & Associates, INC. | $89.22 | 2019 | |
| Novo Nordisk INC | $60.67 | 2024 | |
| Apollo Endosurgery US INC | $44.19 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $39.95 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $32.70 | 2022 | |
| Davol INC. | $31.22 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimitrios Stefanidis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.